Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-12-21

Clinical Trial Update: P. Falciparum Resistance to Artemisinin in Vietnam [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from Vietnam notes artemisinin resistance in Plasmodium falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemisinin (Artemisinin)

Snippet

Sponsor: National Institute of Malariology, Parasitology and Entomology, Vietnam | Conditions: Drug Resistant Malaria Due to Plasmodium Falciparum | Phase 4 | Status: UNKNOWN